Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT05759104
Status:
UNKNOWN
Last Update Posted:
2023-03-08
First Post:
2023-02-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Treatment and Fate in Fistulizing Crohn's Disease in a Pediatric Population
Sponsor:
Central Hospital, Nancy, France
Organization:
Study Overview
Official Title:
Treatment and Fate in Fistulizing Crohn's Disease in a Pediatric Population
Status:
UNKNOWN
Status Verified Date:
2023-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Crohn's disease is a inflammatory bowel disease evolving towards the destruction of the intestinal wall resulting in stenosing or perforating complications (fistulas, abscesses).
The treatment of perforating Crohn's disease is not codified.
The treatment of perforating Crohn's disease is not codified.
Detailed Description:
The old dogmas leading to surgery after failure of medical treatment have recently been overturned, particularly since the advent of anti-TNFs.
Biotherapies now have a central place, including for complicated forms. Previous studies have already looked at the usefulness of anti-TNFs in stenosing forms, or concerning ano-perineal lesions, but what about digestive fistulas.
Indeed, data are scarce, especially in paediatrics.
Biotherapies now have a central place, including for complicated forms. Previous studies have already looked at the usefulness of anti-TNFs in stenosing forms, or concerning ano-perineal lesions, but what about digestive fistulas.
Indeed, data are scarce, especially in paediatrics.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: